AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.9 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review Article | Open Access | Online First

Research progress on new alkaloids of the genus Aspergillus from 2019 to 2024

Ming-Feng He1Jia-Xiang Huang1Shao-Yun Wang1Yong-Qi Tian1,2( )
College of Biological Science and Engineering, Fuzhou University, Fuzhou 350000, China
Fujian Province-Indonesia Marine Food Joint Research and Development Center, Fuzhou 350000, China
Show Author Information

Highlights

(1) The new alkaloids discovered in Aspergillus from 2019 to now and their biological activities are reviewed. It provides a solid foundation for further study on the biological activity and function of these alkaloids.

(2) Of the 245 compounds, 170 were found to have different biological activities, including antibacterial, anti-inflammatory, anti-tumor, and enzyme-inhibiting effects.

(3) This review collates the journals in which these alkaloid structures were published and the nationalities of their discoverers.

Abstract

The genus Aspergillus is a ubiquitous and significant fungus with an increasingly pervasive role in both daily life and the food industry. This article presents a comprehensive overview of the 245 novel alkaloids identified within the Aspergillus genus since 2019. It offers a detailed introduction to the diverse biological activities and functional characteristics exhibited by these compounds, including antibacterial, antiviral, anti-inflammatory, and cytotoxic activity, as well as enzyme inhibition. Additionally, the article provides a detailed analysis of the structural features, publications, and countries of discovery for these alkaloids. It offers strategic guidance for the development of secondary metabolites derived from Aspergillus alkaloids, stimulating innovation in this field.

Graphical Abstract

As illustrated in the graphical abstract, this review summarizes recent advances in novel alkaloids derived from Aspergillus species. Among the reported bioactivities, antibacterial activity accounts for the largest proportion (40.8%), followed by cytotoxic (20.7%), anti-inflammatory (8.3%), enzyme inhibitory (6.5%), and antiviral (4.1%) effects. Structurally, indole alkaloids (34.7%) and piperazine alkaloids (26.5%) are the predominant types, along with noteworthy contributions from pyrrolidine (18.4%) and cyclopeptide (12.2%) alkaloids. The most prolific journals in this field include Mar. Drugs, J. Nat. Prod., Molecules, and Fitoterapia. Geographically, China leads with an overwhelming share of 89.5%, followed by several other countries. Potential applications span drug development, skincare, food science, synthetic biology, and collaborative research across disciplines such as microbiology, chemistry, pharmacology, and bioinformatics.

References

【1】
【1】
 
 
Food & Medicine Homology

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
He M-F, Huang J-X, Wang S-Y, et al. Research progress on new alkaloids of the genus Aspergillus from 2019 to 2024. Food & Medicine Homology, 2026, https://doi.org/10.26599/FMH.2027.9420151

336

Views

70

Downloads

0

Crossref

0

Web of Science

Received: 22 September 2024
Revised: 28 September 2024
Accepted: 29 September 2024
Published: 01 June 2026
© National R & D Center for Edible Fungus Processing Technology 2026. Published by Tsinghua University Press.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).